As an important regulator of glucose metabolism, PDK2 is associated with many diseases, such as tumor metabolic reprogramming, hepatic steatosis, and type 2 diabetes, and is closely correlated with immune cell dysregulation and inflammatory responses (47–49). Here, PDK2 is linked to fatty liver disease.